E-mail: zdenek.racil@uhkt.cz
Odborné práce publikované na Linkos.cz
Přehled odborných textů publikovaných autorem na portálu Linkos.cz. Jsou zde uvedeny knihy a brožury, články v Klinické onkologii, tuzemská abstrakta z databáze abstrakt a další texty. Rejstřík není v žádném případě úplným autorským rejstříkem, protože jsou zde uvedeny pouze texty zveřejněné na portálu Linkos.cz.
Publikovaná abstrakta
- ABNORMALITY OF GLUCOSE AND LIPID METABOLISM DURING NILOTINIB THERAPY – RESULTS OF ENIGMA 2 STUDY
- ARE MUTATIONS IN THE IDH2 GENE SUITABLE MOLECULAR MARKERS FOR MRD MONITORING IN AML PATIENTS?
- AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: STILL NOT OUT OF FASHION
- AUTONOMIC DYSFUNCTION IS AUGMENTED DURING THERAPY, BUT CAN BE IMPROVED BY PHYSICAL EXERCISE IN PATIENTS WITH HEMATOLOGICAL MALIGNANCY. RESULTS OF A PILOT TRIAL.
- CD26 ANTIGEN IS SPECIFIC FOR LEUKEMIC STEM CELLS IN CHRONIC MYELOID LEUKEMIA AND DISTINGUISHES PATIENT GROUPS WITH DIFFERENT RATIOS OF LEUKEMIC AND HEALTHY STEM CELL
- Clinical Manifestation of 1000 Leukemias
- CLINICAL VALUE OF SCREENING DETECTION OF 1,3-BETA-D GLUCAN (BG) FOR EARLY DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS (IFI) IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES - RESULTS OF A PROSPECTIVE STUDY
- CLOFARABINE IN THE TREATMENT OF ACUTE MYELOID LEUKEMIA – SINGLE CENTER EXPERIENCE
- CLOSTRIDIUM DIFFICILE INFECTIONS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCY IN CZECH AND SLOVAK REPUBLIC – A RETROSPECTIVE ANALYSIS
- COMPARISON OF GALACTOMANNAN DETECTED IN SERUM/ BRONCHOALVEOLAR LAVAGE FLUID AND TYPE OF ABNORMALITY ON PULMONARY HIGH RESOLUTION COMPUTER TOMOGRAPHY IN PATIENTS WITH PULMONARY INVASIVE ASPERGILLOSIS
- Comparison of Glucose and Lipid Metabolism Abnormality during Nilotinib, Imatinib and Dasatinib Therapy – Results of Enigma 2 Study
- CONTRIBUTION OF GALACTOMANNAN DETECTION FOR EARLY DIAGNOSIS OF INVASIVE ASPERGILLOSIS IN DIFFERENT GROUPS OF HEMATOONCOLOGICAL PATIENTS
- Cytogenetic Aberration Profile of Chronic Myeloid Leukemia and Its Dynamic Changes During Imatinib Therapy
- DASATINIB EFFICACY AND TOLERANCE IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA (CML) PATIENTS RESISTANT/INTOLERANT TO IMATINIB IN THE CONTEXT OF REAL CLINICAL PRACTICE MANAGEMENT
- Dasatinib Promotes BIM Dependent Apoptosis Via MEK/ERK without Need for Permanent BCR-ABL Inhibition
- Detection of Molecular Relapse of AML by Very Frequent Quantitative Monitoring of Different Molecular Markers (Fusion Transcripts and WT1) in Different Compartments (Peripheral Blood-PB, Bone Marrow-BM, and Selected CD34+ Bone Marrow Cells) and Its..
- Detekce herpetických virů u imunokompromitovaných pacientů metodou „real-time“ PCR
- Doporučené postupy v léčbě invazivních mykóz
- EFFICACY AND TOXICITY OF THE FLAMSA/RIC REGIMEN IN 40 PATIENTS WITH HIGH-RISK AML: A SINGLE CENTRE EXPERIENCE
- ESTIMATION OF THE CURRENT SURVIVAL MEASURES IN CHRONIC MYELOID LEUKEMIA: METHODOLOGY AND NEW SOFTWARE TOOLS
- FIND ´FUNGAL INFECTION DATABASE´ - RETROSPECTIVE ANALYSIS OF INVASIVE ASPERGILLOSIS IN HEMATOONCOLOGICAL DEPARTMENTS IN CZECH AND SLOVAK REPUBLIC BETWEEN 2001-2009
- HIGH RESOLUTION CYTOGENETIC MAPPING AND WHOLE EXOME SEQUENCING REVEAL A COMPLEX PATTERN OF CHROMOSOME 6P ABERRATIONS IN PATIENTS WITH MYELOID MALIGNANCIES
- CHRONIC MYELOID LEUKEMIA: IS THE REAL PROGNOSIS OF NEWLY DIAGNOSED PATIENTS REALLY SO GOOD?
- IMATINIB (IMA) PLASMA CONCENTRATION (PC) MONITORING AND ITS CORRELATION WITH TREATMENT RESPONSE IN CHRONIC MYELOGENOUS LEUKEMIA (CML): A SINGLE CENTRE EXPERIENCE
- IMATINIB IN THE FIRST LINE CHRONIC MYELOID LEUKEMIA (CML) TREATMENT. CAN WE COMPARE THE REAL-LIFE DATA TO CLINICAL TRIAL RESULTS?
- IMPACT OF TREATMENT ADMINISTRATION ON SELECTION OF BCRABL1 KINASE DOMAIN MUTATIONS
- Infekční komplikace léčby maligních lymfomů
- INFUSION OF HLA-MISMATCHED PERIPHERAL BLOOD STEM CELLS DURING TREATMENT AML IN ELDERLY PATIENTS
- MECHANISM OF IMPAIRED GLUCOSE METABOLISM DURING NILOTINIB THERAPY IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA
- Monitoring of Minimal Residual Disease in NPM1 Mutated Acute Myeloid Leukemia (AML) – a Single Center Experience in 27 Patients
- NEUROMUSCULAR TOXICITY OF TYROSINE KINASE INHIBITORS IN THE THERAPY OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA
- P53 Inactivation and Genomic Aberrations in Relation to Imatinib Resistance in Chronic Myeloid Leukemia
- POSACONAZOLE PLASMA LEVELS MONITORING IN HEMATOLOGICAL PATIENTS
- PREDICTION OF IMATINIB THERAPY RESPONSE: A ROLE OF INTRACELLULAR TRANSPORTERS HOCT-1 AND ABCB1
- PROGNOSTIC SIGNIFICANCE OF GENETIC ABERRATIONS IN SECONDARY ACUTE MYELOID LEUKEMIA
- Retrospective Analysis of Minimal Residual Disease-Guided Preemptive Treatment in Patients with AML and MDS - the SAL Study Group Experience
- SKIN ADVERSE EFFECTS OF TYROSINE KINASE INHIBITORS IN THE THERAPY OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA – SINGLE CENTRE EXPERIENCE
- T315I MUTATIONS ARE CLUSTERED WITH ADVANCED PHASES CONTRARY TO OTHER ABERRATIONS IN CML PATIENTS RESISTANT TO TKI THERAPY
- THE DETECTION OF 1,3-?-D-GLUCAN DETECTION IN BRONCHOALVEOLAR LAVAGE FLUID FOR THE DIAGNOSIS OF INVASIVE PULMONARY ASPERGILLOSIS IN HEMATOLOGICAL PATIENTS
- THE DETECTION OF GALACTOMANNAN IN BRONCHOALVEOLAR LAVAGE FLUID FOR THE DIAGNOSTICS OF INVASIVE PULMONARY ASPERGILOSIS IN HEMATOONCOLOGICAL PATIENTS
- The Gene Expressions of hOCT1 and ABCB1 Change During the Course of CML in Relation to Imatinib Therapy
- THE PROSPECTIVE ANALYSIS OF LOW LEVEL BCR-ABL1 T315I MUTATION IN THE CD34+ CELLS OF DE NOVO CML PATIENTS
- TREATMENT OF MOLECULAR RELAPSE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
- TREATMENT OF MOLECULAR RELAPSE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
- USEFULNESS OF THE VORICONAZOLE PLASMA LEVELS MONITORING IN HEMATOONCOLOGICAL PTS TREATED BY ORAL FORM OF THE VORICONAZOLE
- VORICONAZOLE PLASMA CONCENTRATIONS IN HEMATOONCOLOGICAL PATIENTS
- VORICONAZOLE PLASMA LEVELS AND GENETICS POLYMORPHISM OF CYP2C19 IN HEMATOONCOLOGICAL PATIENTS
